MS4A1 and neoplasm: As shown in Figure 7C, treatment with CD20-HSPI&Fe3O4@SiNPs effectively inhibited tumor growth, and the mean survival period of mice treated with CD20-HSPI&Fe3O4@SiNPs was extended to 36 days from 12 days for the control groups (Figure 7D).